Understanding the Value of Response and Early Tumour Shrinkage (ETS) in Pts with Wt kras MCRC Treated with Panitumumab (P) Plus Folfox (F)
Jean‐Yves Douillard(Integrated Oncology (United States)), R. Sidhu(Amgen (United States)), Salvatore Siena(University of Milan), Josep Tabernero(Deaconess Hospital), Chris Davison(Amgen (United Kingdom)), Stephan Braun(Amgen (Switzerland)), Marc Peeters(University of Antwerp)
Cited by 2
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Genomic analysis identifies association of <i>Fusobacterium</i> with colorectal carcinoma
|Genome Research|2011|2k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k